Učitavanje...
Cholangiocarcinoma: novel therapeutic targets
INTRODUCTION: Cholangiocarcinoma (CCA) is a liver cancer derived from the biliary tree with a less than 30% five-year survival rate. Early diagnosis of CCA is challenging and treatment options are limited. Some CCA patients have genetic mutations and several therapeutic drugs or antibodies have been...
Spremljeno u:
| Izdano u: | Expert Opin Ther Targets |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7129482/ https://ncbi.nlm.nih.gov/pubmed/32077341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2020.1733528 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|